Baipharm
ChemLinkedMarketChemicalFoodCosmeticBaiPharm Agrochemical Japan
Webinars
Interactive web-based seminars that provide you opportunities to learn more about compliance solutions and communicate with experts.
All Laws & Regulations Drug Registration DMF New Drugs Generic Drugs Pharmacovigilance MAH System Clinical Trials
[Thursday ,6th April 2023]
Verlene Law
Introduction to Generic Drug Registration in Singapore Introduction to Generic Drug Registration in Singapore
FREE
OPEN FOR REGISTRATION
[Thursday ,16th March 2023]
Alessandra Rolim, Milena Barrozo
Introduction to Marketing Authorization Regulations in Latin America Introduction to Marketing Authorization Regulations in Latin America
FREE
RESOURCE AVAILABLE
[Tuesday ,28th February 2023]
Grace Wang
2022 Recap & 2023 Outlook: China Pharmaceutical Regulatory Updates 2022 Recap & 2023 Outlook: China Pharmaceutical Regulatory Updates
FREE
RESOURCE AVAILABLE
[Tuesday ,20th December 2022]
Ryan Molloy
China Market Entry & Branding for OTC Products China Market Entry & Branding for OTC Products
FREE
RESOURCE AVAILABLE
[Tuesday ,6th December 2022]
Grace Wang
How to Submit New Drug Application (NDA) in China How to Submit New Drug Application (NDA) in China
FREE
RESOURCE AVAILABLE
[Thursday ,3rd November 2022]
Leo Tian
OTC Drug Focus: How to Start and Manage Your Cross-border E-commerce (CBEC) Operations in China OTC Drug Focus: How to Start and Manage Your Cross-border E-commerce (CBEC) Operations in China
FREE
RESOURCE AVAILABLE
[Tuesday ,20th September 2022]
Grace Wang
China's Quality and Therapeutic Equivalence Evaluations of Generic Drugs China's Quality and Therapeutic Equivalence Evaluations of Generic Drugs
FREE
RESOURCE AVAILABLE
[Wednesday ,15th June 2022]
Grace Wang
Understanding Chinese Pharmacopoeia (ChP) 2020 Understanding Chinese Pharmacopoeia (ChP) 2020
FREE
RESOURCE AVAILABLE
[Tuesday ,31st May 2022]
Joy Chen
Decoding China's Drug Marketing Authorization Holder (MAH) System Decoding China's Drug Marketing Authorization Holder (MAH) System
FREE
RESOURCE AVAILABLE
12 Next